Company news

Sensei Biotherapeutics, Inc. news in 2021

Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Sensei Biotherapeutics Named a Winner of Comparably’s Best CEO Award

December 15, 2021

Sensei Biotherapeutics Announces Addition to the Nasdaq Biotechnology Index

December 12, 2021

Sensei Biotherapeutics to Participate in the Piper Sandler 33rd Annual Healthcare Conference

November 18, 2021

Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

November 11, 2021

Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights

November 8, 2021

Sensei Biotherapeutics to Participate in the Berenberg Virtual U.S. CEO Conference on Tuesday, November 9, 2021

November 2, 2021

Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Proprietary Anti-VISTA Antibody, at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

September 30, 2021

Sensei Biotherapeutics Reports Second Quarter 2021 Results and Highlights Recent In Vivo Data from SNS-VISTA Program

August 3, 2021

Sensei Biotherapeutics Appoints Kristian Humer to its Board of Directors

August 1, 2021

Sensei Biotherapeutics Announces Prioritization of Next-Generation Multi-Antigenic ImmunoPhage Platform, Monoclonal Antibody and Nanobody Programs

June 27, 2021

Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck

May 18, 2021

Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update

May 11, 2021

Sensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory Board

May 4, 2021

Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors

April 4, 2021

Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update

March 24, 2021

Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index

March 21, 2021

Sensei Biotherapeutics Announces Closing of Initial Public Offering

February 9, 2021

Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering

February 2, 2021

Calls in 2021

Decks in 2021